113 related articles for article (PubMed ID: 2992962)
1. Antiviral activity in L1210 cells of liposome-encapsulated (2'-5')oligo(adenylate) analogues.
Bayard B; Leserman LD; Bisbal C; Lebleu B
Eur J Biochem; 1985 Sep; 151(2):319-25. PubMed ID: 2992962
[TBL] [Abstract][Full Text] [Related]
2. Increased stability and antiviral activity of 2'-O-phosphoglyceryl derivatives of (2'-5')oligo(adenylate).
Bayard B; Bisbal C; Silhol M; Cnockaert J; Huez G; Lebleu B
Eur J Biochem; 1984 Jul; 142(2):291-8. PubMed ID: 6086347
[TBL] [Abstract][Full Text] [Related]
3. 2'5' Oligoadenylate analogues:synthesis, biological activities and intracellular delivery.
Bisbal C; Bayard B; Silhol M; Leserman L; Lebleu B
Prog Clin Biol Res; 1985; 202():89-95. PubMed ID: 3008175
[No Abstract] [Full Text] [Related]
4. Activation of ribonuclease L by (2'-5')(A)4-poly(L-lysine) conjugates in intact cells.
Bayard B; Bisbal C; Lebleu B
Biochemistry; 1986 Jun; 25(12):3730-6. PubMed ID: 3013297
[TBL] [Abstract][Full Text] [Related]
5. 5'-modified agonist and antagonist (2'-5')(A)n analogues: synthesis and biological activity.
Bisbal C; Silhol M; Lemaître M; Bayard B; Salehzada T; Lebleu B; Perrée TD; Blackburn MG
Biochemistry; 1987 Aug; 26(16):5172-8. PubMed ID: 3117112
[TBL] [Abstract][Full Text] [Related]
6. Anticellular and antiviral effects of pppA(2'p5'A)n.
Hovanessian AG; Wood JN
Virology; 1980 Feb; 101(1):81-90. PubMed ID: 6243832
[No Abstract] [Full Text] [Related]
7. Mechanism of interferon action III--significance of pppA2'p5'A2'p5'A in the antiviral action of interferon.
Liu XY; Yao K; Zhou YX; Jin JR; Wen YM; Lou YC; Li BL; Wang DB
Sci Sin B; 1983 Aug; 26(8):809-17. PubMed ID: 6194560
[TBL] [Abstract][Full Text] [Related]
8. Effect of 2'5'-oligoadenylic acid on a mouse cell line partially resistant to interferon.
Panet A; Czarniecki CW; Falk H; Friedman RM
Virology; 1981 Oct; 114(2):567-72. PubMed ID: 6170160
[No Abstract] [Full Text] [Related]
9. Recruiting the 2-5A system for antisense therapeutics.
Torrence PF; Xiao W; Li G; Cramer H; Player MR; Silverman RH
Antisense Nucleic Acid Drug Dev; 1997 Jun; 7(3):203-6. PubMed ID: 9212911
[No Abstract] [Full Text] [Related]
10. 2',5'-Oligoadenylates and related 2',5'-oligonucleotide analogues. 2. Effect on cellular proliferation, protein synthesis, and endoribonuclease activity.
Hughes BG; Robins RK
Biochemistry; 1983 Apr; 22(9):2127-35. PubMed ID: 6860653
[TBL] [Abstract][Full Text] [Related]
11. Respective role of each of the purine N7 nitrogens of 5'-O-triphosphoadenylyl(2'----5')adenylyl(2'----5')adenosine in binding to and activation of the RNase L of mouse cells.
Jamoulle JC; Lesiak K; Torrence PF
Biochemistry; 1987 Jan; 26(2):376-83. PubMed ID: 3030408
[TBL] [Abstract][Full Text] [Related]
12. A 2',5'-oligoadenylate analogue inhibits murine hepatitis virus strain 3 (MHV-3) replication in vitro but does not reduce MHV-3-related mortality or induction of procoagulant activity in susceptible mice.
Fingerote RJ; Cruz BM; Gorczynski RM; Fung LS; Hubbell HR; Suhadolnik RJ; Levy GA
J Gen Virol; 1995 Feb; 76 ( Pt 2)():373-80. PubMed ID: 7844557
[TBL] [Abstract][Full Text] [Related]
13. Interferon action may be mediated by activation of a nuclease by pppA2'p5'A2'p5'A.
Baglioni C; Minks MA; Maroney PA
Nature; 1978 Jun; 273(5664):684-7. PubMed ID: 208001
[No Abstract] [Full Text] [Related]
14. Characterization of RNABP, an RNA binding protein that associates with RNase L.
Le Roy F; Laskowska A; Silhol M; Salehzada T; Bisbal C
J Interferon Cytokine Res; 2000 Jul; 20(7):635-44. PubMed ID: 10926206
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and breakdown of pppA2'p5'A2'p5'A and transient inhibiton of protein synthesis in extracts from interferon-treated and control cells.
Williams BR; Kerr IM; Gilbert CS; White CN; Ball LA
Eur J Biochem; 1978 Dec; 92(2):455-62. PubMed ID: 216547
[TBL] [Abstract][Full Text] [Related]
16. Small-molecule activators of RNase L with broad-spectrum antiviral activity.
Thakur CS; Jha BK; Dong B; Das Gupta J; Silverman KM; Mao H; Sawai H; Nakamura AO; Banerjee AK; Gudkov A; Silverman RH
Proc Natl Acad Sci U S A; 2007 Jun; 104(23):9585-90. PubMed ID: 17535916
[TBL] [Abstract][Full Text] [Related]
17. Chemistry and biochemistry of 2',5'-oligoadenylate-based antisense strategy.
Adah SA; Bayly SF; Cramer H; Silverman RH; Torrence PF
Curr Med Chem; 2001 Aug; 8(10):1189-212. PubMed ID: 11472236
[TBL] [Abstract][Full Text] [Related]
18. n-Decyl-NHpppA2'p5'A2'p5'A A phosphatase-resistant, active pppA2'p5'A2'p5'A analog.
Karikó K; Ludwig J
Biochem Biophys Res Commun; 1985 Apr; 128(2):695-8. PubMed ID: 2581566
[TBL] [Abstract][Full Text] [Related]
19. Antiviral activity of a chemically stabilized 2-5A analog upon microinjection into HeLa cells.
Defilippi P; Huez G; Verhaegen-Lawalle M; De Clercq E; Imai J; Torrence P; Content J
FEBS Lett; 1986 Mar; 198(2):326-32. PubMed ID: 2420642
[TBL] [Abstract][Full Text] [Related]
20. rRNA cleavage as an index of ppp(A2'p)nA activity in interferon-treated encephalomyocarditis virus-infected cells.
Silverman RH; Skehel JJ; James TC; Wreschner DH; Kerr IM
J Virol; 1983 Jun; 46(3):1051-5. PubMed ID: 6190010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
